Global Vaccine for Influenza Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Semiconductor Pedestals market size is predicted to grow from US$ 521 million in 2025 to US$ 702 million in 2031; it is expected to grow at a CAGR of 5.1% from 2025 to 2031.
This studies the semiconductor pedestals, covers the metal pedestals and ceramic pedestals, used for electrostatic chucks and wafer heaters, etc.
Semiconductor manufacturing equipment is a medium tool for achieving semiconductor manufacturing processes, playing an important role in all aspects. According to SEMI, worldwide sales of semiconductor manufacturing equipment increased 5% from $102.6 billion in 2021 to an all-time record of $107.6 billion in 2022.
In recent years, the localization process of China's semiconductor industry has further accelerated, and the performance of semiconductor equipment is more flexible than the overall industry. The localization of semiconductor equipment is ushering in a golden wave, and domestic semiconductor equipment is facing more opportunities for verification and trial use, technical cooperation, and import substitution. For the third consecutive year, China remained the largest semiconductor equipment market in 2022 despite a 5% slowdown in the pace of investments in the region year over year, accounting for $28.3 billion in billings.
The record high for semiconductor manufacturing equipment sales in 2022 stems from the industry’s drive to add the fab capacity required to support long-term growth and innovations in key end markets including high-performance computing and automotive. Additionally, the results reflect investments and determination across regions to avoid future semiconductor supply chain constraints like those that surfaced during the pandemic.
LP Information, Inc. (LPI) ' newest research report, the “Semiconductor Pedestals Industry Forecast” looks at past sales and reviews total world Semiconductor Pedestals sales in 2024, providing a comprehensive analysis by region and market sector of projected Semiconductor Pedestals sales for 2025 through 2031. With Semiconductor Pedestals sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Semiconductor Pedestals industry.
This Insight Report provides a comprehensive analysis of the global Semiconductor Pedestals landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Semiconductor Pedestals portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Semiconductor Pedestals market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Semiconductor Pedestals and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Semiconductor Pedestals.
This report presents a comprehensive overview, market shares, and growth opportunities of Semiconductor Pedestals market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Semiconductor Pedestals market?
What factors are driving Semiconductor Pedestals market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Semiconductor Pedestals market opportunities vary by end market size?
How does Semiconductor Pedestals break out by Type, by Application?
The global Semiconductor Pedestals market size is predicted to grow from US$ 521 million in 2025 to US$ 702 million in 2031; it is expected to grow at a CAGR of 5.1% from 2025 to 2031.
This studies the semiconductor pedestals, covers the metal pedestals and ceramic pedestals, used for electrostatic chucks and wafer heaters, etc.
Semiconductor manufacturing equipment is a medium tool for achieving semiconductor manufacturing processes, playing an important role in all aspects. According to SEMI, worldwide sales of semiconductor manufacturing equipment increased 5% from $102.6 billion in 2021 to an all-time record of $107.6 billion in 2022.
In recent years, the localization process of China's semiconductor industry has further accelerated, and the performance of semiconductor equipment is more flexible than the overall industry. The localization of semiconductor equipment is ushering in a golden wave, and domestic semiconductor equipment is facing more opportunities for verification and trial use, technical cooperation, and import substitution. For the third consecutive year, China remained the largest semiconductor equipment market in 2022 despite a 5% slowdown in the pace of investments in the region year over year, accounting for $28.3 billion in billings.
The record high for semiconductor manufacturing equipment sales in 2022 stems from the industry’s drive to add the fab capacity required to support long-term growth and innovations in key end markets including high-performance computing and automotive. Additionally, the results reflect investments and determination across regions to avoid future semiconductor supply chain constraints like those that surfaced during the pandemic.
LP Information, Inc. (LPI) ' newest research report, the “Semiconductor Pedestals Industry Forecast” looks at past sales and reviews total world Semiconductor Pedestals sales in 2024, providing a comprehensive analysis by region and market sector of projected Semiconductor Pedestals sales for 2025 through 2031. With Semiconductor Pedestals sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Semiconductor Pedestals industry.
This Insight Report provides a comprehensive analysis of the global Semiconductor Pedestals landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Semiconductor Pedestals portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Semiconductor Pedestals market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Semiconductor Pedestals and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Semiconductor Pedestals.
This report presents a comprehensive overview, market shares, and growth opportunities of Semiconductor Pedestals market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Metal Pedestal
- Ceramic Pedestal
- 300mm System
- 200mm System
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Applied Materials (AMAT)
- Lam Research
- Technetics Semi
- Therm-x
- Cast Aluminum Solutions (CAS)
- Durex Industries
- Watlow (CRC)
- Backer AB
- BoBoo Hitech
- CoorsTek
- SemiXicon
- NGK Insulators (NTK Ceratec)
- Kyocera
- Shinko Electric Industries
- TOTO
- II-VI
- AK Tech Co.,Ltd
- MiCo Ceramics
- Fralock (Oasis Materials)
- Sumitomo Electric
What is the 10-year outlook for the global Semiconductor Pedestals market?
What factors are driving Semiconductor Pedestals market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Semiconductor Pedestals market opportunities vary by end market size?
How does Semiconductor Pedestals break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Vaccine for Influenza Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Vaccine for Influenza by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Vaccine for Influenza by Country/Region, 2020, 2024 & 2031
2.2 Vaccine for Influenza Segment by Type
2.2.1 Trivalent Influenza Vaccine
2.2.2 Quadrivalent Influenza Vaccine
2.3 Vaccine for Influenza Sales by Type
2.3.1 Global Vaccine for Influenza Sales Market Share by Type (2020-2025)
2.3.2 Global Vaccine for Influenza Revenue and Market Share by Type (2020-2025)
2.3.3 Global Vaccine for Influenza Sale Price by Type (2020-2025)
2.4 Vaccine for Influenza Segment by Application
2.4.1 6 Months to 3 Years
2.4.2 > 3 Years
2.5 Vaccine for Influenza Sales by Application
2.5.1 Global Vaccine for Influenza Sale Market Share by Application (2020-2025)
2.5.2 Global Vaccine for Influenza Revenue and Market Share by Application (2020-2025)
2.5.3 Global Vaccine for Influenza Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Vaccine for Influenza Breakdown Data by Company
3.1.1 Global Vaccine for Influenza Annual Sales by Company (2020-2025)
3.1.2 Global Vaccine for Influenza Sales Market Share by Company (2020-2025)
3.2 Global Vaccine for Influenza Annual Revenue by Company (2020-2025)
3.2.1 Global Vaccine for Influenza Revenue by Company (2020-2025)
3.2.2 Global Vaccine for Influenza Revenue Market Share by Company (2020-2025)
3.3 Global Vaccine for Influenza Sale Price by Company
3.4 Key Manufacturers Vaccine for Influenza Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Vaccine for Influenza Product Location Distribution
3.4.2 Players Vaccine for Influenza Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR VACCINE FOR INFLUENZA BY GEOGRAPHIC REGION
4.1 World Historic Vaccine for Influenza Market Size by Geographic Region (2020-2025)
4.1.1 Global Vaccine for Influenza Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Vaccine for Influenza Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Vaccine for Influenza Market Size by Country/Region (2020-2025)
4.2.1 Global Vaccine for Influenza Annual Sales by Country/Region (2020-2025)
4.2.2 Global Vaccine for Influenza Annual Revenue by Country/Region (2020-2025)
4.3 Americas Vaccine for Influenza Sales Growth
4.4 APAC Vaccine for Influenza Sales Growth
4.5 Europe Vaccine for Influenza Sales Growth
4.6 Middle East & Africa Vaccine for Influenza Sales Growth
5 AMERICAS
5.1 Americas Vaccine for Influenza Sales by Country
5.1.1 Americas Vaccine for Influenza Sales by Country (2020-2025)
5.1.2 Americas Vaccine for Influenza Revenue by Country (2020-2025)
5.2 Americas Vaccine for Influenza Sales by Type (2020-2025)
5.3 Americas Vaccine for Influenza Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vaccine for Influenza Sales by Region
6.1.1 APAC Vaccine for Influenza Sales by Region (2020-2025)
6.1.2 APAC Vaccine for Influenza Revenue by Region (2020-2025)
6.2 APAC Vaccine for Influenza Sales by Type (2020-2025)
6.3 APAC Vaccine for Influenza Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Vaccine for Influenza by Country
7.1.1 Europe Vaccine for Influenza Sales by Country (2020-2025)
7.1.2 Europe Vaccine for Influenza Revenue by Country (2020-2025)
7.2 Europe Vaccine for Influenza Sales by Type (2020-2025)
7.3 Europe Vaccine for Influenza Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Vaccine for Influenza by Country
8.1.1 Middle East & Africa Vaccine for Influenza Sales by Country (2020-2025)
8.1.2 Middle East & Africa Vaccine for Influenza Revenue by Country (2020-2025)
8.2 Middle East & Africa Vaccine for Influenza Sales by Type (2020-2025)
8.3 Middle East & Africa Vaccine for Influenza Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Vaccine for Influenza
10.3 Manufacturing Process Analysis of Vaccine for Influenza
10.4 Industry Chain Structure of Vaccine for Influenza
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Vaccine for Influenza Distributors
11.3 Vaccine for Influenza Customer
12 WORLD FORECAST REVIEW FOR VACCINE FOR INFLUENZA BY GEOGRAPHIC REGION
12.1 Global Vaccine for Influenza Market Size Forecast by Region
12.1.1 Global Vaccine for Influenza Forecast by Region (2026-2031)
12.1.2 Global Vaccine for Influenza Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Vaccine for Influenza Forecast by Type (2026-2031)
12.7 Global Vaccine for Influenza Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Vaccine for Influenza Product Portfolios and Specifications
13.1.3 Sanofi Vaccine for Influenza Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 CSL
13.2.1 CSL Company Information
13.2.2 CSL Vaccine for Influenza Product Portfolios and Specifications
13.2.3 CSL Vaccine for Influenza Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 CSL Main Business Overview
13.2.5 CSL Latest Developments
13.3 GSK
13.3.1 GSK Company Information
13.3.2 GSK Vaccine for Influenza Product Portfolios and Specifications
13.3.3 GSK Vaccine for Influenza Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 GSK Main Business Overview
13.3.5 GSK Latest Developments
13.4 Viatris
13.4.1 Viatris Company Information
13.4.2 Viatris Vaccine for Influenza Product Portfolios and Specifications
13.4.3 Viatris Vaccine for Influenza Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Viatris Main Business Overview
13.4.5 Viatris Latest Developments
13.5 AstraZeneca
13.5.1 AstraZeneca Company Information
13.5.2 AstraZeneca Vaccine for Influenza Product Portfolios and Specifications
13.5.3 AstraZeneca Vaccine for Influenza Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 AstraZeneca Main Business Overview
13.5.5 AstraZeneca Latest Developments
13.6 Hualan Bio
13.6.1 Hualan Bio Company Information
13.6.2 Hualan Bio Vaccine for Influenza Product Portfolios and Specifications
13.6.3 Hualan Bio Vaccine for Influenza Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Hualan Bio Main Business Overview
13.6.5 Hualan Bio Latest Developments
13.7 Changchun Institute of Biological
13.7.1 Changchun Institute of Biological Company Information
13.7.2 Changchun Institute of Biological Vaccine for Influenza Product Portfolios and Specifications
13.7.3 Changchun Institute of Biological Vaccine for Influenza Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Changchun Institute of Biological Main Business Overview
13.7.5 Changchun Institute of Biological Latest Developments
13.8 Sinovac
13.8.1 Sinovac Company Information
13.8.2 Sinovac Vaccine for Influenza Product Portfolios and Specifications
13.8.3 Sinovac Vaccine for Influenza Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Sinovac Main Business Overview
13.8.5 Sinovac Latest Developments
13.9 BCHT
13.9.1 BCHT Company Information
13.9.2 BCHT Vaccine for Influenza Product Portfolios and Specifications
13.9.3 BCHT Vaccine for Influenza Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 BCHT Main Business Overview
13.9.5 BCHT Latest Developments
13.10 Jiangsu GDK
13.10.1 Jiangsu GDK Company Information
13.10.2 Jiangsu GDK Vaccine for Influenza Product Portfolios and Specifications
13.10.3 Jiangsu GDK Vaccine for Influenza Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Jiangsu GDK Main Business Overview
13.10.5 Jiangsu GDK Latest Developments
13.11 KM Biologics
13.11.1 KM Biologics Company Information
13.11.2 KM Biologics Vaccine for Influenza Product Portfolios and Specifications
13.11.3 KM Biologics Vaccine for Influenza Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 KM Biologics Main Business Overview
13.11.5 KM Biologics Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Vaccine for Influenza Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Vaccine for Influenza by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Vaccine for Influenza by Country/Region, 2020, 2024 & 2031
2.2 Vaccine for Influenza Segment by Type
2.2.1 Trivalent Influenza Vaccine
2.2.2 Quadrivalent Influenza Vaccine
2.3 Vaccine for Influenza Sales by Type
2.3.1 Global Vaccine for Influenza Sales Market Share by Type (2020-2025)
2.3.2 Global Vaccine for Influenza Revenue and Market Share by Type (2020-2025)
2.3.3 Global Vaccine for Influenza Sale Price by Type (2020-2025)
2.4 Vaccine for Influenza Segment by Application
2.4.1 6 Months to 3 Years
2.4.2 > 3 Years
2.5 Vaccine for Influenza Sales by Application
2.5.1 Global Vaccine for Influenza Sale Market Share by Application (2020-2025)
2.5.2 Global Vaccine for Influenza Revenue and Market Share by Application (2020-2025)
2.5.3 Global Vaccine for Influenza Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Vaccine for Influenza Breakdown Data by Company
3.1.1 Global Vaccine for Influenza Annual Sales by Company (2020-2025)
3.1.2 Global Vaccine for Influenza Sales Market Share by Company (2020-2025)
3.2 Global Vaccine for Influenza Annual Revenue by Company (2020-2025)
3.2.1 Global Vaccine for Influenza Revenue by Company (2020-2025)
3.2.2 Global Vaccine for Influenza Revenue Market Share by Company (2020-2025)
3.3 Global Vaccine for Influenza Sale Price by Company
3.4 Key Manufacturers Vaccine for Influenza Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Vaccine for Influenza Product Location Distribution
3.4.2 Players Vaccine for Influenza Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR VACCINE FOR INFLUENZA BY GEOGRAPHIC REGION
4.1 World Historic Vaccine for Influenza Market Size by Geographic Region (2020-2025)
4.1.1 Global Vaccine for Influenza Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Vaccine for Influenza Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Vaccine for Influenza Market Size by Country/Region (2020-2025)
4.2.1 Global Vaccine for Influenza Annual Sales by Country/Region (2020-2025)
4.2.2 Global Vaccine for Influenza Annual Revenue by Country/Region (2020-2025)
4.3 Americas Vaccine for Influenza Sales Growth
4.4 APAC Vaccine for Influenza Sales Growth
4.5 Europe Vaccine for Influenza Sales Growth
4.6 Middle East & Africa Vaccine for Influenza Sales Growth
5 AMERICAS
5.1 Americas Vaccine for Influenza Sales by Country
5.1.1 Americas Vaccine for Influenza Sales by Country (2020-2025)
5.1.2 Americas Vaccine for Influenza Revenue by Country (2020-2025)
5.2 Americas Vaccine for Influenza Sales by Type (2020-2025)
5.3 Americas Vaccine for Influenza Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vaccine for Influenza Sales by Region
6.1.1 APAC Vaccine for Influenza Sales by Region (2020-2025)
6.1.2 APAC Vaccine for Influenza Revenue by Region (2020-2025)
6.2 APAC Vaccine for Influenza Sales by Type (2020-2025)
6.3 APAC Vaccine for Influenza Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Vaccine for Influenza by Country
7.1.1 Europe Vaccine for Influenza Sales by Country (2020-2025)
7.1.2 Europe Vaccine for Influenza Revenue by Country (2020-2025)
7.2 Europe Vaccine for Influenza Sales by Type (2020-2025)
7.3 Europe Vaccine for Influenza Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Vaccine for Influenza by Country
8.1.1 Middle East & Africa Vaccine for Influenza Sales by Country (2020-2025)
8.1.2 Middle East & Africa Vaccine for Influenza Revenue by Country (2020-2025)
8.2 Middle East & Africa Vaccine for Influenza Sales by Type (2020-2025)
8.3 Middle East & Africa Vaccine for Influenza Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Vaccine for Influenza
10.3 Manufacturing Process Analysis of Vaccine for Influenza
10.4 Industry Chain Structure of Vaccine for Influenza
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Vaccine for Influenza Distributors
11.3 Vaccine for Influenza Customer
12 WORLD FORECAST REVIEW FOR VACCINE FOR INFLUENZA BY GEOGRAPHIC REGION
12.1 Global Vaccine for Influenza Market Size Forecast by Region
12.1.1 Global Vaccine for Influenza Forecast by Region (2026-2031)
12.1.2 Global Vaccine for Influenza Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Vaccine for Influenza Forecast by Type (2026-2031)
12.7 Global Vaccine for Influenza Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Vaccine for Influenza Product Portfolios and Specifications
13.1.3 Sanofi Vaccine for Influenza Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 CSL
13.2.1 CSL Company Information
13.2.2 CSL Vaccine for Influenza Product Portfolios and Specifications
13.2.3 CSL Vaccine for Influenza Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 CSL Main Business Overview
13.2.5 CSL Latest Developments
13.3 GSK
13.3.1 GSK Company Information
13.3.2 GSK Vaccine for Influenza Product Portfolios and Specifications
13.3.3 GSK Vaccine for Influenza Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 GSK Main Business Overview
13.3.5 GSK Latest Developments
13.4 Viatris
13.4.1 Viatris Company Information
13.4.2 Viatris Vaccine for Influenza Product Portfolios and Specifications
13.4.3 Viatris Vaccine for Influenza Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Viatris Main Business Overview
13.4.5 Viatris Latest Developments
13.5 AstraZeneca
13.5.1 AstraZeneca Company Information
13.5.2 AstraZeneca Vaccine for Influenza Product Portfolios and Specifications
13.5.3 AstraZeneca Vaccine for Influenza Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 AstraZeneca Main Business Overview
13.5.5 AstraZeneca Latest Developments
13.6 Hualan Bio
13.6.1 Hualan Bio Company Information
13.6.2 Hualan Bio Vaccine for Influenza Product Portfolios and Specifications
13.6.3 Hualan Bio Vaccine for Influenza Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Hualan Bio Main Business Overview
13.6.5 Hualan Bio Latest Developments
13.7 Changchun Institute of Biological
13.7.1 Changchun Institute of Biological Company Information
13.7.2 Changchun Institute of Biological Vaccine for Influenza Product Portfolios and Specifications
13.7.3 Changchun Institute of Biological Vaccine for Influenza Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Changchun Institute of Biological Main Business Overview
13.7.5 Changchun Institute of Biological Latest Developments
13.8 Sinovac
13.8.1 Sinovac Company Information
13.8.2 Sinovac Vaccine for Influenza Product Portfolios and Specifications
13.8.3 Sinovac Vaccine for Influenza Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Sinovac Main Business Overview
13.8.5 Sinovac Latest Developments
13.9 BCHT
13.9.1 BCHT Company Information
13.9.2 BCHT Vaccine for Influenza Product Portfolios and Specifications
13.9.3 BCHT Vaccine for Influenza Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 BCHT Main Business Overview
13.9.5 BCHT Latest Developments
13.10 Jiangsu GDK
13.10.1 Jiangsu GDK Company Information
13.10.2 Jiangsu GDK Vaccine for Influenza Product Portfolios and Specifications
13.10.3 Jiangsu GDK Vaccine for Influenza Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Jiangsu GDK Main Business Overview
13.10.5 Jiangsu GDK Latest Developments
13.11 KM Biologics
13.11.1 KM Biologics Company Information
13.11.2 KM Biologics Vaccine for Influenza Product Portfolios and Specifications
13.11.3 KM Biologics Vaccine for Influenza Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 KM Biologics Main Business Overview
13.11.5 KM Biologics Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Vaccine for Influenza Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Vaccine for Influenza Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Trivalent Influenza Vaccine
Table 4. Major Players of Quadrivalent Influenza Vaccine
Table 5. Global Vaccine for Influenza Sales by Type (2020-2025) & (M Units)
Table 6. Global Vaccine for Influenza Sales Market Share by Type (2020-2025)
Table 7. Global Vaccine for Influenza Revenue by Type (2020-2025) & ($ million)
Table 8. Global Vaccine for Influenza Revenue Market Share by Type (2020-2025)
Table 9. Global Vaccine for Influenza Sale Price by Type (2020-2025) & (US$/Unit)
Table 10. Global Vaccine for Influenza Sale by Application (2020-2025) & (M Units)
Table 11. Global Vaccine for Influenza Sale Market Share by Application (2020-2025)
Table 12. Global Vaccine for Influenza Revenue by Application (2020-2025) & ($ million)
Table 13. Global Vaccine for Influenza Revenue Market Share by Application (2020-2025)
Table 14. Global Vaccine for Influenza Sale Price by Application (2020-2025) & (US$/Unit)
Table 15. Global Vaccine for Influenza Sales by Company (2020-2025) & (M Units)
Table 16. Global Vaccine for Influenza Sales Market Share by Company (2020-2025)
Table 17. Global Vaccine for Influenza Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Vaccine for Influenza Revenue Market Share by Company (2020-2025)
Table 19. Global Vaccine for Influenza Sale Price by Company (2020-2025) & (US$/Unit)
Table 20. Key Manufacturers Vaccine for Influenza Producing Area Distribution and Sales Area
Table 21. Players Vaccine for Influenza Products Offered
Table 22. Vaccine for Influenza Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Vaccine for Influenza Sales by Geographic Region (2020-2025) & (M Units)
Table 26. Global Vaccine for Influenza Sales Market Share Geographic Region (2020-2025)
Table 27. Global Vaccine for Influenza Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Vaccine for Influenza Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Vaccine for Influenza Sales by Country/Region (2020-2025) & (M Units)
Table 30. Global Vaccine for Influenza Sales Market Share by Country/Region (2020-2025)
Table 31. Global Vaccine for Influenza Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Vaccine for Influenza Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Vaccine for Influenza Sales by Country (2020-2025) & (M Units)
Table 34. Americas Vaccine for Influenza Sales Market Share by Country (2020-2025)
Table 35. Americas Vaccine for Influenza Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Vaccine for Influenza Sales by Type (2020-2025) & (M Units)
Table 37. Americas Vaccine for Influenza Sales by Application (2020-2025) & (M Units)
Table 38. APAC Vaccine for Influenza Sales by Region (2020-2025) & (M Units)
Table 39. APAC Vaccine for Influenza Sales Market Share by Region (2020-2025)
Table 40. APAC Vaccine for Influenza Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Vaccine for Influenza Sales by Type (2020-2025) & (M Units)
Table 42. APAC Vaccine for Influenza Sales by Application (2020-2025) & (M Units)
Table 43. Europe Vaccine for Influenza Sales by Country (2020-2025) & (M Units)
Table 44. Europe Vaccine for Influenza Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Vaccine for Influenza Sales by Type (2020-2025) & (M Units)
Table 46. Europe Vaccine for Influenza Sales by Application (2020-2025) & (M Units)
Table 47. Middle East & Africa Vaccine for Influenza Sales by Country (2020-2025) & (M Units)
Table 48. Middle East & Africa Vaccine for Influenza Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Vaccine for Influenza Sales by Type (2020-2025) & (M Units)
Table 50. Middle East & Africa Vaccine for Influenza Sales by Application (2020-2025) & (M Units)
Table 51. Key Market Drivers & Growth Opportunities of Vaccine for Influenza
Table 52. Key Market Challenges & Risks of Vaccine for Influenza
Table 53. Key Industry Trends of Vaccine for Influenza
Table 54. Vaccine for Influenza Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Vaccine for Influenza Distributors List
Table 57. Vaccine for Influenza Customer List
Table 58. Global Vaccine for Influenza Sales Forecast by Region (2026-2031) & (M Units)
Table 59. Global Vaccine for Influenza Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Vaccine for Influenza Sales Forecast by Country (2026-2031) & (M Units)
Table 61. Americas Vaccine for Influenza Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Vaccine for Influenza Sales Forecast by Region (2026-2031) & (M Units)
Table 63. APAC Vaccine for Influenza Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Vaccine for Influenza Sales Forecast by Country (2026-2031) & (M Units)
Table 65. Europe Vaccine for Influenza Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Vaccine for Influenza Sales Forecast by Country (2026-2031) & (M Units)
Table 67. Middle East & Africa Vaccine for Influenza Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Vaccine for Influenza Sales Forecast by Type (2026-2031) & (M Units)
Table 69. Global Vaccine for Influenza Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Vaccine for Influenza Sales Forecast by Application (2026-2031) & (M Units)
Table 71. Global Vaccine for Influenza Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Sanofi Basic Information, Vaccine for Influenza Manufacturing Base, Sales Area and Its Competitors
Table 73. Sanofi Vaccine for Influenza Product Portfolios and Specifications
Table 74. Sanofi Vaccine for Influenza Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. Sanofi Main Business
Table 76. Sanofi Latest Developments
Table 77. CSL Basic Information, Vaccine for Influenza Manufacturing Base, Sales Area and Its Competitors
Table 78. CSL Vaccine for Influenza Product Portfolios and Specifications
Table 79. CSL Vaccine for Influenza Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. CSL Main Business
Table 81. CSL Latest Developments
Table 82. GSK Basic Information, Vaccine for Influenza Manufacturing Base, Sales Area and Its Competitors
Table 83. GSK Vaccine for Influenza Product Portfolios and Specifications
Table 84. GSK Vaccine for Influenza Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. GSK Main Business
Table 86. GSK Latest Developments
Table 87. Viatris Basic Information, Vaccine for Influenza Manufacturing Base, Sales Area and Its Competitors
Table 88. Viatris Vaccine for Influenza Product Portfolios and Specifications
Table 89. Viatris Vaccine for Influenza Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Viatris Main Business
Table 91. Viatris Latest Developments
Table 92. AstraZeneca Basic Information, Vaccine for Influenza Manufacturing Base, Sales Area and Its Competitors
Table 93. AstraZeneca Vaccine for Influenza Product Portfolios and Specifications
Table 94. AstraZeneca Vaccine for Influenza Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. AstraZeneca Main Business
Table 96. AstraZeneca Latest Developments
Table 97. Hualan Bio Basic Information, Vaccine for Influenza Manufacturing Base, Sales Area and Its Competitors
Table 98. Hualan Bio Vaccine for Influenza Product Portfolios and Specifications
Table 99. Hualan Bio Vaccine for Influenza Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. Hualan Bio Main Business
Table 101. Hualan Bio Latest Developments
Table 102. Changchun Institute of Biological Basic Information, Vaccine for Influenza Manufacturing Base, Sales Area and Its Competitors
Table 103. Changchun Institute of Biological Vaccine for Influenza Product Portfolios and Specifications
Table 104. Changchun Institute of Biological Vaccine for Influenza Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. Changchun Institute of Biological Main Business
Table 106. Changchun Institute of Biological Latest Developments
Table 107. Sinovac Basic Information, Vaccine for Influenza Manufacturing Base, Sales Area and Its Competitors
Table 108. Sinovac Vaccine for Influenza Product Portfolios and Specifications
Table 109. Sinovac Vaccine for Influenza Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 110. Sinovac Main Business
Table 111. Sinovac Latest Developments
Table 112. BCHT Basic Information, Vaccine for Influenza Manufacturing Base, Sales Area and Its Competitors
Table 113. BCHT Vaccine for Influenza Product Portfolios and Specifications
Table 114. BCHT Vaccine for Influenza Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 115. BCHT Main Business
Table 116. BCHT Latest Developments
Table 117. Jiangsu GDK Basic Information, Vaccine for Influenza Manufacturing Base, Sales Area and Its Competitors
Table 118. Jiangsu GDK Vaccine for Influenza Product Portfolios and Specifications
Table 119. Jiangsu GDK Vaccine for Influenza Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 120. Jiangsu GDK Main Business
Table 121. Jiangsu GDK Latest Developments
Table 122. KM Biologics Basic Information, Vaccine for Influenza Manufacturing Base, Sales Area and Its Competitors
Table 123. KM Biologics Vaccine for Influenza Product Portfolios and Specifications
Table 124. KM Biologics Vaccine for Influenza Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 125. KM Biologics Main Business
Table 126. KM Biologics Latest Developments
Table 1. Vaccine for Influenza Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Vaccine for Influenza Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Trivalent Influenza Vaccine
Table 4. Major Players of Quadrivalent Influenza Vaccine
Table 5. Global Vaccine for Influenza Sales by Type (2020-2025) & (M Units)
Table 6. Global Vaccine for Influenza Sales Market Share by Type (2020-2025)
Table 7. Global Vaccine for Influenza Revenue by Type (2020-2025) & ($ million)
Table 8. Global Vaccine for Influenza Revenue Market Share by Type (2020-2025)
Table 9. Global Vaccine for Influenza Sale Price by Type (2020-2025) & (US$/Unit)
Table 10. Global Vaccine for Influenza Sale by Application (2020-2025) & (M Units)
Table 11. Global Vaccine for Influenza Sale Market Share by Application (2020-2025)
Table 12. Global Vaccine for Influenza Revenue by Application (2020-2025) & ($ million)
Table 13. Global Vaccine for Influenza Revenue Market Share by Application (2020-2025)
Table 14. Global Vaccine for Influenza Sale Price by Application (2020-2025) & (US$/Unit)
Table 15. Global Vaccine for Influenza Sales by Company (2020-2025) & (M Units)
Table 16. Global Vaccine for Influenza Sales Market Share by Company (2020-2025)
Table 17. Global Vaccine for Influenza Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Vaccine for Influenza Revenue Market Share by Company (2020-2025)
Table 19. Global Vaccine for Influenza Sale Price by Company (2020-2025) & (US$/Unit)
Table 20. Key Manufacturers Vaccine for Influenza Producing Area Distribution and Sales Area
Table 21. Players Vaccine for Influenza Products Offered
Table 22. Vaccine for Influenza Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Vaccine for Influenza Sales by Geographic Region (2020-2025) & (M Units)
Table 26. Global Vaccine for Influenza Sales Market Share Geographic Region (2020-2025)
Table 27. Global Vaccine for Influenza Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Vaccine for Influenza Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Vaccine for Influenza Sales by Country/Region (2020-2025) & (M Units)
Table 30. Global Vaccine for Influenza Sales Market Share by Country/Region (2020-2025)
Table 31. Global Vaccine for Influenza Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Vaccine for Influenza Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Vaccine for Influenza Sales by Country (2020-2025) & (M Units)
Table 34. Americas Vaccine for Influenza Sales Market Share by Country (2020-2025)
Table 35. Americas Vaccine for Influenza Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Vaccine for Influenza Sales by Type (2020-2025) & (M Units)
Table 37. Americas Vaccine for Influenza Sales by Application (2020-2025) & (M Units)
Table 38. APAC Vaccine for Influenza Sales by Region (2020-2025) & (M Units)
Table 39. APAC Vaccine for Influenza Sales Market Share by Region (2020-2025)
Table 40. APAC Vaccine for Influenza Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Vaccine for Influenza Sales by Type (2020-2025) & (M Units)
Table 42. APAC Vaccine for Influenza Sales by Application (2020-2025) & (M Units)
Table 43. Europe Vaccine for Influenza Sales by Country (2020-2025) & (M Units)
Table 44. Europe Vaccine for Influenza Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Vaccine for Influenza Sales by Type (2020-2025) & (M Units)
Table 46. Europe Vaccine for Influenza Sales by Application (2020-2025) & (M Units)
Table 47. Middle East & Africa Vaccine for Influenza Sales by Country (2020-2025) & (M Units)
Table 48. Middle East & Africa Vaccine for Influenza Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Vaccine for Influenza Sales by Type (2020-2025) & (M Units)
Table 50. Middle East & Africa Vaccine for Influenza Sales by Application (2020-2025) & (M Units)
Table 51. Key Market Drivers & Growth Opportunities of Vaccine for Influenza
Table 52. Key Market Challenges & Risks of Vaccine for Influenza
Table 53. Key Industry Trends of Vaccine for Influenza
Table 54. Vaccine for Influenza Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Vaccine for Influenza Distributors List
Table 57. Vaccine for Influenza Customer List
Table 58. Global Vaccine for Influenza Sales Forecast by Region (2026-2031) & (M Units)
Table 59. Global Vaccine for Influenza Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Vaccine for Influenza Sales Forecast by Country (2026-2031) & (M Units)
Table 61. Americas Vaccine for Influenza Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Vaccine for Influenza Sales Forecast by Region (2026-2031) & (M Units)
Table 63. APAC Vaccine for Influenza Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Vaccine for Influenza Sales Forecast by Country (2026-2031) & (M Units)
Table 65. Europe Vaccine for Influenza Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Vaccine for Influenza Sales Forecast by Country (2026-2031) & (M Units)
Table 67. Middle East & Africa Vaccine for Influenza Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Vaccine for Influenza Sales Forecast by Type (2026-2031) & (M Units)
Table 69. Global Vaccine for Influenza Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Vaccine for Influenza Sales Forecast by Application (2026-2031) & (M Units)
Table 71. Global Vaccine for Influenza Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Sanofi Basic Information, Vaccine for Influenza Manufacturing Base, Sales Area and Its Competitors
Table 73. Sanofi Vaccine for Influenza Product Portfolios and Specifications
Table 74. Sanofi Vaccine for Influenza Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. Sanofi Main Business
Table 76. Sanofi Latest Developments
Table 77. CSL Basic Information, Vaccine for Influenza Manufacturing Base, Sales Area and Its Competitors
Table 78. CSL Vaccine for Influenza Product Portfolios and Specifications
Table 79. CSL Vaccine for Influenza Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. CSL Main Business
Table 81. CSL Latest Developments
Table 82. GSK Basic Information, Vaccine for Influenza Manufacturing Base, Sales Area and Its Competitors
Table 83. GSK Vaccine for Influenza Product Portfolios and Specifications
Table 84. GSK Vaccine for Influenza Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. GSK Main Business
Table 86. GSK Latest Developments
Table 87. Viatris Basic Information, Vaccine for Influenza Manufacturing Base, Sales Area and Its Competitors
Table 88. Viatris Vaccine for Influenza Product Portfolios and Specifications
Table 89. Viatris Vaccine for Influenza Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Viatris Main Business
Table 91. Viatris Latest Developments
Table 92. AstraZeneca Basic Information, Vaccine for Influenza Manufacturing Base, Sales Area and Its Competitors
Table 93. AstraZeneca Vaccine for Influenza Product Portfolios and Specifications
Table 94. AstraZeneca Vaccine for Influenza Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. AstraZeneca Main Business
Table 96. AstraZeneca Latest Developments
Table 97. Hualan Bio Basic Information, Vaccine for Influenza Manufacturing Base, Sales Area and Its Competitors
Table 98. Hualan Bio Vaccine for Influenza Product Portfolios and Specifications
Table 99. Hualan Bio Vaccine for Influenza Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. Hualan Bio Main Business
Table 101. Hualan Bio Latest Developments
Table 102. Changchun Institute of Biological Basic Information, Vaccine for Influenza Manufacturing Base, Sales Area and Its Competitors
Table 103. Changchun Institute of Biological Vaccine for Influenza Product Portfolios and Specifications
Table 104. Changchun Institute of Biological Vaccine for Influenza Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. Changchun Institute of Biological Main Business
Table 106. Changchun Institute of Biological Latest Developments
Table 107. Sinovac Basic Information, Vaccine for Influenza Manufacturing Base, Sales Area and Its Competitors
Table 108. Sinovac Vaccine for Influenza Product Portfolios and Specifications
Table 109. Sinovac Vaccine for Influenza Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 110. Sinovac Main Business
Table 111. Sinovac Latest Developments
Table 112. BCHT Basic Information, Vaccine for Influenza Manufacturing Base, Sales Area and Its Competitors
Table 113. BCHT Vaccine for Influenza Product Portfolios and Specifications
Table 114. BCHT Vaccine for Influenza Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 115. BCHT Main Business
Table 116. BCHT Latest Developments
Table 117. Jiangsu GDK Basic Information, Vaccine for Influenza Manufacturing Base, Sales Area and Its Competitors
Table 118. Jiangsu GDK Vaccine for Influenza Product Portfolios and Specifications
Table 119. Jiangsu GDK Vaccine for Influenza Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 120. Jiangsu GDK Main Business
Table 121. Jiangsu GDK Latest Developments
Table 122. KM Biologics Basic Information, Vaccine for Influenza Manufacturing Base, Sales Area and Its Competitors
Table 123. KM Biologics Vaccine for Influenza Product Portfolios and Specifications
Table 124. KM Biologics Vaccine for Influenza Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 125. KM Biologics Main Business
Table 126. KM Biologics Latest Developments
LIST OF FIGURES
Figure 1. Picture of Vaccine for Influenza
Figure 2. Vaccine for Influenza Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Vaccine for Influenza Sales Growth Rate 2020-2031 (M Units)
Figure 7. Global Vaccine for Influenza Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Vaccine for Influenza Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Vaccine for Influenza Sales Market Share by Country/Region (2024)
Figure 10. Vaccine for Influenza Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Trivalent Influenza Vaccine
Figure 12. Product Picture of Quadrivalent Influenza Vaccine
Figure 13. Global Vaccine for Influenza Sales Market Share by Type in 2025
Figure 14. Global Vaccine for Influenza Revenue Market Share by Type (2020-2025)
Figure 15. Vaccine for Influenza Consumed in 6 Months to 3 Years
Figure 16. Global Vaccine for Influenza Market: 6 Months to 3 Years (2020-2025) & (M Units)
Figure 17. Vaccine for Influenza Consumed in > 3 Years
Figure 18. Global Vaccine for Influenza Market: > 3 Years (2020-2025) & (M Units)
Figure 19. Global Vaccine for Influenza Sale Market Share by Application (2024)
Figure 20. Global Vaccine for Influenza Revenue Market Share by Application in 2025
Figure 21. Vaccine for Influenza Sales by Company in 2025 (M Units)
Figure 22. Global Vaccine for Influenza Sales Market Share by Company in 2025
Figure 23. Vaccine for Influenza Revenue by Company in 2025 ($ millions)
Figure 24. Global Vaccine for Influenza Revenue Market Share by Company in 2025
Figure 25. Global Vaccine for Influenza Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Vaccine for Influenza Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Vaccine for Influenza Sales 2020-2025 (M Units)
Figure 28. Americas Vaccine for Influenza Revenue 2020-2025 ($ millions)
Figure 29. APAC Vaccine for Influenza Sales 2020-2025 (M Units)
Figure 30. APAC Vaccine for Influenza Revenue 2020-2025 ($ millions)
Figure 31. Europe Vaccine for Influenza Sales 2020-2025 (M Units)
Figure 32. Europe Vaccine for Influenza Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Vaccine for Influenza Sales 2020-2025 (M Units)
Figure 34. Middle East & Africa Vaccine for Influenza Revenue 2020-2025 ($ millions)
Figure 35. Americas Vaccine for Influenza Sales Market Share by Country in 2025
Figure 36. Americas Vaccine for Influenza Revenue Market Share by Country (2020-2025)
Figure 37. Americas Vaccine for Influenza Sales Market Share by Type (2020-2025)
Figure 38. Americas Vaccine for Influenza Sales Market Share by Application (2020-2025)
Figure 39. United States Vaccine for Influenza Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Vaccine for Influenza Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Vaccine for Influenza Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Vaccine for Influenza Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Vaccine for Influenza Sales Market Share by Region in 2025
Figure 44. APAC Vaccine for Influenza Revenue Market Share by Region (2020-2025)
Figure 45. APAC Vaccine for Influenza Sales Market Share by Type (2020-2025)
Figure 46. APAC Vaccine for Influenza Sales Market Share by Application (2020-2025)
Figure 47. China Vaccine for Influenza Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Vaccine for Influenza Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Vaccine for Influenza Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Vaccine for Influenza Revenue Growth 2020-2025 ($ millions)
Figure 51. India Vaccine for Influenza Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Vaccine for Influenza Revenue Growth 2020-2025 ($ millions)
Figure 53. ChinaTaiwan Vaccine for Influenza Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Vaccine for Influenza Sales Market Share by Country in 2025
Figure 55. Europe Vaccine for Influenza Revenue Market Share by Country (2020-2025)
Figure 56. Europe Vaccine for Influenza Sales Market Share by Type (2020-2025)
Figure 57. Europe Vaccine for Influenza Sales Market Share by Application (2020-2025)
Figure 58. Germany Vaccine for Influenza Revenue Growth 2020-2025 ($ millions)
Figure 59. France Vaccine for Influenza Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Vaccine for Influenza Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Vaccine for Influenza Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Vaccine for Influenza Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Vaccine for Influenza Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Vaccine for Influenza Sales Market Share by Type (2020-2025)
Figure 65. Middle East & Africa Vaccine for Influenza Sales Market Share by Application (2020-2025)
Figure 66. Egypt Vaccine for Influenza Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Vaccine for Influenza Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Vaccine for Influenza Revenue Growth 2020-2025 ($ millions)
Figure 69. Turkey Vaccine for Influenza Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Vaccine for Influenza Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Vaccine for Influenza in 2025
Figure 72. Manufacturing Process Analysis of Vaccine for Influenza
Figure 73. Industry Chain Structure of Vaccine for Influenza
Figure 74. Channels of Distribution
Figure 75. Global Vaccine for Influenza Sales Market Forecast by Region (2026-2031)
Figure 76. Global Vaccine for Influenza Revenue Market Share Forecast by Region (2026-2031)
Figure 77. Global Vaccine for Influenza Sales Market Share Forecast by Type (2026-2031)
Figure 78. Global Vaccine for Influenza Revenue Market Share Forecast by Type (2026-2031)
Figure 79. Global Vaccine for Influenza Sales Market Share Forecast by Application (2026-2031)
Figure 80. Global Vaccine for Influenza Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Vaccine for Influenza
Figure 2. Vaccine for Influenza Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Vaccine for Influenza Sales Growth Rate 2020-2031 (M Units)
Figure 7. Global Vaccine for Influenza Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Vaccine for Influenza Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Vaccine for Influenza Sales Market Share by Country/Region (2024)
Figure 10. Vaccine for Influenza Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Trivalent Influenza Vaccine
Figure 12. Product Picture of Quadrivalent Influenza Vaccine
Figure 13. Global Vaccine for Influenza Sales Market Share by Type in 2025
Figure 14. Global Vaccine for Influenza Revenue Market Share by Type (2020-2025)
Figure 15. Vaccine for Influenza Consumed in 6 Months to 3 Years
Figure 16. Global Vaccine for Influenza Market: 6 Months to 3 Years (2020-2025) & (M Units)
Figure 17. Vaccine for Influenza Consumed in > 3 Years
Figure 18. Global Vaccine for Influenza Market: > 3 Years (2020-2025) & (M Units)
Figure 19. Global Vaccine for Influenza Sale Market Share by Application (2024)
Figure 20. Global Vaccine for Influenza Revenue Market Share by Application in 2025
Figure 21. Vaccine for Influenza Sales by Company in 2025 (M Units)
Figure 22. Global Vaccine for Influenza Sales Market Share by Company in 2025
Figure 23. Vaccine for Influenza Revenue by Company in 2025 ($ millions)
Figure 24. Global Vaccine for Influenza Revenue Market Share by Company in 2025
Figure 25. Global Vaccine for Influenza Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Vaccine for Influenza Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Vaccine for Influenza Sales 2020-2025 (M Units)
Figure 28. Americas Vaccine for Influenza Revenue 2020-2025 ($ millions)
Figure 29. APAC Vaccine for Influenza Sales 2020-2025 (M Units)
Figure 30. APAC Vaccine for Influenza Revenue 2020-2025 ($ millions)
Figure 31. Europe Vaccine for Influenza Sales 2020-2025 (M Units)
Figure 32. Europe Vaccine for Influenza Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Vaccine for Influenza Sales 2020-2025 (M Units)
Figure 34. Middle East & Africa Vaccine for Influenza Revenue 2020-2025 ($ millions)
Figure 35. Americas Vaccine for Influenza Sales Market Share by Country in 2025
Figure 36. Americas Vaccine for Influenza Revenue Market Share by Country (2020-2025)
Figure 37. Americas Vaccine for Influenza Sales Market Share by Type (2020-2025)
Figure 38. Americas Vaccine for Influenza Sales Market Share by Application (2020-2025)
Figure 39. United States Vaccine for Influenza Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Vaccine for Influenza Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Vaccine for Influenza Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Vaccine for Influenza Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Vaccine for Influenza Sales Market Share by Region in 2025
Figure 44. APAC Vaccine for Influenza Revenue Market Share by Region (2020-2025)
Figure 45. APAC Vaccine for Influenza Sales Market Share by Type (2020-2025)
Figure 46. APAC Vaccine for Influenza Sales Market Share by Application (2020-2025)
Figure 47. China Vaccine for Influenza Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Vaccine for Influenza Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Vaccine for Influenza Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Vaccine for Influenza Revenue Growth 2020-2025 ($ millions)
Figure 51. India Vaccine for Influenza Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Vaccine for Influenza Revenue Growth 2020-2025 ($ millions)
Figure 53. ChinaTaiwan Vaccine for Influenza Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Vaccine for Influenza Sales Market Share by Country in 2025
Figure 55. Europe Vaccine for Influenza Revenue Market Share by Country (2020-2025)
Figure 56. Europe Vaccine for Influenza Sales Market Share by Type (2020-2025)
Figure 57. Europe Vaccine for Influenza Sales Market Share by Application (2020-2025)
Figure 58. Germany Vaccine for Influenza Revenue Growth 2020-2025 ($ millions)
Figure 59. France Vaccine for Influenza Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Vaccine for Influenza Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Vaccine for Influenza Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Vaccine for Influenza Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Vaccine for Influenza Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Vaccine for Influenza Sales Market Share by Type (2020-2025)
Figure 65. Middle East & Africa Vaccine for Influenza Sales Market Share by Application (2020-2025)
Figure 66. Egypt Vaccine for Influenza Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Vaccine for Influenza Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Vaccine for Influenza Revenue Growth 2020-2025 ($ millions)
Figure 69. Turkey Vaccine for Influenza Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Vaccine for Influenza Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Vaccine for Influenza in 2025
Figure 72. Manufacturing Process Analysis of Vaccine for Influenza
Figure 73. Industry Chain Structure of Vaccine for Influenza
Figure 74. Channels of Distribution
Figure 75. Global Vaccine for Influenza Sales Market Forecast by Region (2026-2031)
Figure 76. Global Vaccine for Influenza Revenue Market Share Forecast by Region (2026-2031)
Figure 77. Global Vaccine for Influenza Sales Market Share Forecast by Type (2026-2031)
Figure 78. Global Vaccine for Influenza Revenue Market Share Forecast by Type (2026-2031)
Figure 79. Global Vaccine for Influenza Sales Market Share Forecast by Application (2026-2031)
Figure 80. Global Vaccine for Influenza Revenue Market Share Forecast by Application (2026-2031)
More Publications
Global Reprocessed Medical Device Market Growth 2025-2031
US$ 3,660.00
March 2025
88 pages
Global Prescription Pain Relievers Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
119 pages
Global Hydroxy Camptothecine (HCPT) Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
123 pages
Global Protein Electrophoresis Apparatus Market Growth 2023-2029
US$ 3,660.00
February 2023
93 pages
Global Pulsed Lavage System Market Growth 2023-2029
US$ 3,660.00
February 2023
98 pages
